Lung transplantation (LTx) for fibrotic diseases: a single centre experience

G. M. Verleden, L. J. Dupont, D. E. Van Raemdonck (Leuven, Belgium)

Source: Annual Congress 2005 - Clinical issues before and after lung transplantation
Session: Clinical issues before and after lung transplantation
Session type: Thematic Poster Session
Number: 4035
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. M. Verleden, L. J. Dupont, D. E. Van Raemdonck (Leuven, Belgium). Lung transplantation (LTx) for fibrotic diseases: a single centre experience. Eur Respir J 2005; 26: Suppl. 49, 4035

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Lung transplantation: the ideal treatment for diffuse disease?
Source: Annual Congress 2006 - Up to date management of bronchiectasis
Year: 2006


Lung transplantation in rare lung diseases: the problem of chronic lung allograft dysfunction (CLAD)
Source: International Congress 2018 – Rare lung diseases
Year: 2018


Paediatric lung transplantation
Source: Eur Respir J 2004; 24 : 839-845
Year: 2004



Panel discussion: COVID-19 and lung transplantation: how to handle?
Source: ERS webinar 2022

Access for REGISTERED non-members

Year: 2022

Paediatric lung transplantation
Source: ISSN=1025-448x, ISBN=1-904097-29-4, page=243
Year: 2003

Lung transplantation for lymphangioleiomyomatosis: a Brazilian centre experience.
Source: International Congress 2017 – Rare diseases
Year: 2017


Pediatric lung transplantation: a single center experience
Source: Eur Respir J 2006; 28: Suppl. 50, 780s
Year: 2006

Lung transplant outcomes in bronchiectasis –a single center experience
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Year: 2019

Rapid decline in lung disease other than COPD: when should lung transplantation be considered?
Source: Annual Congress 2007 - Rapid decline in lung function and its consequences
Year: 2007


Lung transplantation (LT) for late onset of non infectious pulmonary complications (LONIPC) after haematopoietic stem cell transplantation (HSCT): Results from a French adult cohort
Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation
Year: 2010

Idiopathic pulmonaryfibrosis: the native lung after single lung transplantation
Source: Eur Respir J 2003; 22: Suppl. 45, 328s
Year: 2003

Effects of pulmonary rehabilitation following single (SLTX) or double (DLTX) lung transplantation
Source: Eur Respir J 2001; 18: Suppl. 33, 355s
Year: 2001

Mortality in idiopathic pulmonary fibrosis (IPF) on the waiting list for lung transplantation in the Netherlands
Source: Annual Congress 2011 - Lung transplantation
Year: 2011

Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT)
Source: Annual Congress 2013 –Diffuse parenchymal lung disease I
Year: 2013


Effects of pulmonary rehabilitation in a specialized centre following single (SLTx) or double (DLTx) lung transplantation
Source: Eur Respir J 2006; 28: Suppl. 50, 723s
Year: 2006

Paediatric lung transplantation: a single center experience in France
Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings
Year: 2009

The diaphragm before and after lung transplant (LT)
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018

Better survival outcomes after bilateral lung transplantation compared to single lung transplantation in patients with idiopathic pulmonary fibrosis
Source: Annual Congress 2013 –Clinical studies in lung transplantation
Year: 2013

Lung transplantation in systemic sclerosis: Experience in a spanish center
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014